Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid
- PMID: 3353318
Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid
Similar articles
-
Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.Arch Dermatol Res. 1982;273(1-2):111-4. doi: 10.1007/BF00509034. Arch Dermatol Res. 1982. PMID: 7184466
-
Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.Eur J Clin Pharmacol. 1982;23(1):75-80. doi: 10.1007/BF01061380. Eur J Clin Pharmacol. 1982. PMID: 7128674
-
[Influence of retinoids on the bioavailability of methoxy-8-psoralen].Ann Dermatol Venereol. 1991;118(4):273-5. Ann Dermatol Venereol. 1991. PMID: 2069337 French.
-
[The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].Derm Beruf Umwelt. 1988 Nov-Dec;36(6):177-85. Derm Beruf Umwelt. 1988. PMID: 3069432 Review. German.
-
[Psoriasis treatment by a photochemotherapy (PUVA) method].Vestn Dermatol Venerol. 1980 Oct;(10):4-7. Vestn Dermatol Venerol. 1980. PMID: 6449792 Review. Russian. No abstract available.
Cited by
-
Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.Arch Dermatol Res. 1991;283(5):297-9. doi: 10.1007/BF00376617. Arch Dermatol Res. 1991. PMID: 1929553